American Society of Hematology

SHERPA: Blue

People

  1. O'Reilly
    O'Reilly
  2. Kernan
    Kernan
  3. Papadopoulos
    Papadopoulos
  4. Perales
    Perales
  5. Castro-Malaspina
    Castro-Malaspina
  6. Giralt
    Giralt
  7. Young
    Young
  8. Jakubowski
    Jakubowski
  9. Scaradavou
    Scaradavou
  10. Heller
    Heller

Groups

  1. Immunology Program Faculty (487)
  2. Sloan Kettering Institute Faculty (487)
  3. Department of Medicine (480)
  4. GSK Faculty (476)
  5. Center for Hematologic Malignancies (367)
  6. Hematologic Malignancies, Division of (363)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (309)
  8. Pediatrics, Department of (293)
  9. Tow Center for Developmental Oncology (TCDO) (293)
  10. Stem Cell Transplantation and Cellular Therapy Service (285)
Search Within
  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (362)
  2. Journal Article (125)
Groups
  1. Immunology Program Faculty (487)
  2. Sloan Kettering Institute Faculty (487)
  3. Department of Medicine (480)
  4. GSK Faculty (476)
  5. Center for Hematologic Malignancies (367)
  6. Hematologic Malignancies, Division of (363)

More Groups

People
  1. Richard O'Reilly (281)
  2. Marcel Van Den Brink (220)
  3. Nancy Kernan (130)
  4. Farid Boulad (103)
  5. Esperanza Papadopoulos (99)
  6. Trudy Small (98)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (17)
  4. 2022 (16)
  5. 2021 (9)
  6. 2020 (7)

More Years

Publications
  1. Blood (474)
  2. Blood Advances (12)
  3. Hematology-American Society of Hematology Education Program (1)

Results (487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Effector differentiation and exhaustion attenuate on-target, off-tumor toxicity of CD24 CAR T cells
    Meeting Abstract

    Boardman, A. P.; Rajagopalan, A.; Chen, S.; Ng, B.; Fischman, J.; Massa, A.; Elias, H. K.; Manuele, D.; Atmane, M. I.; Miranda, I.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Regulatory T cell derived trefoil factor 1 drives thymic regeneration in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Pierce, J.; Gipson, B.; Serrano-Marin, L.; Argyropoulos, K.; Dewolf, S.; James, S. E.; Kaur, M.; Kousa, A.; Nguyen, C. L.; Rajagopalan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model
    Journal Article

    Ng, B. D.; Rajagopalan, A.; Kousa, A. I.; Fischman, J. S.; Chen, S.; Massa, A.; Elias, H. K.; Manuele, D.; Galiano, M.; Lemarquis, A. L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation
    Meeting Abstract

    Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CCR1-targeting CAR T cells for acute myeloid leukemia
    Meeting Abstract

    Chen, S.; Boardman, A. P.; James, S. E.; van den Brink, M. R. M.
    Blood (2023)

    Fulltext@MSK | Save
  • Low CD117 expression identifies hematopoietic stem cell subsets with enhanced lymphoid potential in mice and humans
    Meeting Abstract

    Elias, H. K.; Mitra, S.; Gipson, B.; da Silva, M. B.; Lee, N.; Ali, M. A. E.; Grassman, S.; Kousa, A.; DeWolf, S.; Park, C. Y.; more...
    Blood (2023)

    Fulltext@MSK | Save